Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 1/20 | 0.31 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL28194789 | 0.98 | — | — | |
| SCHEMBL22485390 | 0.86 | — | — | |
| SCHEMBL11226280 | 0.84 | MEN1 (0.37) | TOP2ATOP2BMEN1KMT2A | |
| SCHEMBL12259537 | 0.84 | MEN1 (0.37) | TOP2ATOP2BMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL28245775 | 0.79 | SMN1; SMN2 (0.33) | — | |
| Bromide SCHEMBL28851069 | 0.79 | SMN1; SMN2 (0.30) | — | |
| SCHEMBL1102255 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL10515769 | 0.77 | — | — | |
| SCHEMBL18487768 | 0.76 | SLC6A2 (0.33) | MEN1KMT2A | |
| SCHEMBL3381915 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110072919-A | Polyorganosiloxane, polyorganosiloxane composition, cured product thereof, electrolyte solution for electrolytic capacitor containing polyorganosiloxane, and electrolytic capacitor using same | 三菱化学株式会社 | 2019-07-30 | — | — | CN | disclosed |
| US-20180148440-A1 | SUBSTITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180148440-A1 | SUBSTITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS | RYR2, SLC8B1, P2RX1 | TOP2A 4361/4885TOP2B 4390/4885MEN1 2519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.